Downloads: 229

Files in This Item:
File Description SizeFormat 
1749-8090-5-47.pdf1.53 MBAdobe PDFView/Open
Title: Effective cardiac resynchronization therapy for an adolescent patient with dilated cardiomyopathy seven years after mitral valve replacement and septal anterior ventricular exclusion.
Authors: Mima, Takahiro
Baba, Shiro  kyouindb  KAKEN_id
Yokoo, Noritaka
Kaichi, Shinji
Doi, Takahiro  KAKEN_id
Doi, Hiraku
Heike, Toshio  kyouindb  KAKEN_id
Author's alias: 馬場, 志郎
Issue Date: 3-Jun-2010
Publisher: BioMed Central Ltd.
Journal title: Journal of cardiothoracic surgery
Volume: 5
Thesis number: 47
Abstract: Cardiac resynchronization therapy (CRT) is a new treatment for refractory heart failure. However, most heart failure patients treated with CRT are middle-aged or old patients with idiopathic or ischemic dilated cardiomyopathy. We treated a 17 year 11 month old girl with dilated cardiomyopathy after mitral valve replacement (MVR) and septal anterior ventricular exclusion (SAVE). Seven years after the SAVE procedure, she presented complaining of palpitations and general fatigue with normal activity. Her echocardiogram showed reduced left ventricular function. Despite of optimal medical therapy, her left ventricular function continued to decline and she experienced regular arrhythmias such as premature ventricular contractions. We thus elected to perform cardiac resynchronization therapy with defibrillator (CRT-D). After CRT-D, her clinical symptoms improved dramatically and left ventricular ejection fraction (LVEF) improved from 31.2% to 51.3% as assessed by echocardiogram. Serum BNP levels decreased from 448.2 to 213.6 pg/ml. On ECG, arrhythmias were remarkably reduced and QRS duration was shortened from 174 to 152 msec. In conclusion, CRT-D is an effective therapeutic option for adolescent patients with refractory heart failure after left ventricular volume reduction surgery.
Rights: © 2010 Mima et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
URI: http://hdl.handle.net/2433/159709
DOI(Published Version): 10.1186/1749-8090-5-47
PubMed ID: 20525228
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.